Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

287 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biomarkers for Huntington's disease: an update.
Scahill RI, Wild EJ, Tabrizi SJ. Scahill RI, et al. Expert Opin Med Diagn. 2012 Sep;6(5):371-5. doi: 10.1517/17530059.2012.701205. Epub 2012 Jun 24. Expert Opin Med Diagn. 2012. PMID: 23480802
Biochemical abnormalities and excitotoxicity in Huntington's disease brain.
Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH. Tabrizi SJ, et al. Ann Neurol. 1999 Jan;45(1):25-32. doi: 10.1002/1531-8249(199901)45:1<25::aid-art6>3.0.co;2-e. Ann Neurol. 1999. PMID: 9894873
Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.
Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, Cooper JM, Schapira AH. Tabrizi SJ, et al. Ann Neurol. 2000 Jan;47(1):80-6. doi: 10.1002/1531-8249(200001)47:1<80::aid-ana13>3.3.co;2-b. Ann Neurol. 2000. PMID: 10632104
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.
Tabrizi SJ, Blamire AM, Manners DN, Rajagopalan B, Styles P, Schapira AH, Warner TT. Tabrizi SJ, et al. Neurology. 2003 Jul 8;61(1):141-2. doi: 10.1212/01.wnl.0000070186.97463.a7. Neurology. 2003. PMID: 12847181 Clinical Trial. No abstract available.
High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.
Tabrizi SJ, Blamire AM, Manners DN, Rajagopalan B, Styles P, Schapira AH, Warner TT. Tabrizi SJ, et al. Neurology. 2005 May 10;64(9):1655-6. doi: 10.1212/01.WNL.0000160388.96242.77. Neurology. 2005. PMID: 15883340 Clinical Trial. No abstract available.
Biomarkers for neurodegenerative diseases.
Henley SM, Bates GP, Tabrizi SJ. Henley SM, et al. Curr Opin Neurol. 2005 Dec;18(6):698-705. doi: 10.1097/01.wco.0000186842.51129.cb. Curr Opin Neurol. 2005. PMID: 16280682 Review.
Identification of an oculomotor biomarker of preclinical Huntington disease.
Golding CV, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C. Golding CV, et al. Neurology. 2006 Aug 8;67(3):485-7. doi: 10.1212/01.wnl.0000218215.43328.88. Epub 2006 Apr 19. Neurology. 2006. PMID: 16625001
Increased rate of whole-brain atrophy over 6 months in early Huntington disease.
Henley SM, Frost C, MacManus DG, Warner TT, Fox NC, Tabrizi SJ. Henley SM, et al. Neurology. 2006 Aug 22;67(4):694-6. doi: 10.1212/01.wnl.0000230149.36635.c8. Neurology. 2006. PMID: 16924028 Clinical Trial.
Proteome-based plasma biomarkers for Alzheimer's disease.
Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F, Tabrizi SJ, Banner S, Shaw CE, Foy C, Poppe M, Archer N, Hamilton G, Powell J, Brown RG, Sham P, Ward M, Lovestone S. Hye A, et al. Brain. 2006 Nov;129(Pt 11):3042-50. doi: 10.1093/brain/awl279. Brain. 2006. PMID: 17071923
Imaging microglial activation in Huntington's disease.
Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Tai YF, et al. Brain Res Bull. 2007 Apr 30;72(2-3):148-51. doi: 10.1016/j.brainresbull.2006.10.029. Epub 2006 Nov 27. Brain Res Bull. 2007. PMID: 17352938 Review.
287 results
Jump to page
Feedback